Bleeding is a common complication after percutaneous nephrolithotomy (PNL) for renal stone disease. Tranexamic acid (TXA) has been found to reduce mortality and blood transfusion in surgical and trauma patients. This review aimed to assess the safety and efficacy of TXA in patients undergoing PNL.
Tópico:
Kidney Stones and Urolithiasis Treatments
Citaciones:
8
Citaciones por año:
Altmétricas:
0
Información de la Fuente:
FuenteAnnals of The Royal College of Surgeons of England
